Mark Adkins

New FDA-registerred incontinence solutions. Sanitis and Consure Medical Announce Long-Term Partnership for the sales and distribution of Consure’s incontinence solutions. Many of you are you used to seeing our posts about EVS and productivity enhancement tools, but what you may not realize is that Sanitis is also a distributor of medical supplies and innovative medical devices that provide better patient outcomes and safety. It is for this reason that Sanitis is excited to announce that, due to our remarkable growth over the last 13 years, we are expanding our product portfolio through our recent agreement with Consure Medical to offer their novel fecal and urinary incontinence solutions. Consure Medical's ground-breaking automated fecal management system, Qoramatic, and their superior female urinary incontinence system, Qivi, set new standards in their product categories. Qoramatic is an FDA-registered automated system that manages fecal incontinence with reduced need for nurses' interventions by 90%. Qoramatic also provides a safer and more comfortable solution for patients with greatly reduced leakage, odor, and chances for the spread of HAI's. Qivi on the other hand is an EXTERNAL female catheter that eliminates the problems inherent in other catheters by reducing the chances of urinary tract infections, providing a better fit for more patients, less leakage, and less skin irritation and ulceration. The partnership extends Saniti’s portfolio into the medical incontinence markets, a key category for the company, and is designed to significantly expand Consure’s sales and distribution to continue the brand's accelerated growth. Through this partnership, we will further strengthen our efforts in order to promote the business of both companies by leveraging our respective strengths and services. For more information on Qoramatic or Qivi, contact us at [email protected] or (888) 789-6266. We look forward to helping you! #incontinence #UTI

17

Years after the global pandemic broke out, supply chain disruptions continue to linger, impacting multiple industries. MedTech companies are challenged with building resiliency programs to ensure the proper equipment is available and ready for patient care. We work with organizations to incorporate sustainable strategies into their digital thread initiatives like design-anywhere/manufacture-anywhere, so they can continue providing critical assets needed to treat and save patients. Dave Hadfield outlines how in our latest MedTech Viewpoint article: https://hubs.ly/Q02Xw5lb0 #MedTech #supplychain #digitaltransformation

11

Tune in to the most recent episode of Funding Medtech Podcast to listen to Jeremy Langsam at Portal Innovations, LLC and Rich Mazzola at Project Medtech discuss the details (the network, investment thesis, check size, etc.) of Portal Innovations. Links to the podcast, monthly newsletter, and website are in the comments below! Follow Project Medtech on LinkedIn for more great content or visit our website #medicaldevices #startup #medtech #projectmedtech #innovation #medicaldevice #podcast #strategy

44

5 Comments

Being #successful is more important than being fast. And being nimble and agile throughout the process is critical to success. If you're bringing a product to market, don't just prototype products you know are already possible to make and simple to execute; work on the complex details that make your product special. By leveraging advanced prototyping methods, focusing on complex development aspects, and proactively collaborating with your customers, you too can overcome the challenges of a fast-paced global economy. For MedTech leaders, it could mean the difference between failure and gaining a competitive edge. #medtech #innovation #medicaldevices #entrepreneurship #startups

6

Spine Deshittification (Thank you Mitch Johnson for coining the phrase) In 30+ years in this crazy business, I have never worked in spine.  Some customers are actually brain surgeons – and the surgical technology reflects it – VR, robotics, navigation. Yet “workhorse” devices, upon which outcomes often depend, have had little recent R&D investment. This hasn’t gone unnoticed. A prominent spine surgeon told me, “There are a shed-load of interbody cages with no evidence that any one product or approach is superior to another. In our health system, we will move to a ‘generic’ platform because we can’t justify increased expense for ‘proprietary” devices. In 2-3 years, devices will be off the market unless they clearly demonstrate a value proposition.” In the last 5 years, better battery chemistry and low power sensors have allowed Canary to significantly shrink our CHIRP implant. We can now create a “cartridge” suitable for insertion into interbody cages in a manner similar to cementless knee, hip and shoulder products under development with Zimmer Biomet. ALL of these devices have received FDA breakthrough designation. Heel strike during walking sends a shockwave through the skeleton. Accelerometers, gyroscopes and step counters implanted in the disc space can measure and quantify activity (step count, cadence, walking speed, stride length, distance); at high fidelity (3200 observations/second) they can detect subvisual spinal segment movement (range of motion, gait, vibration). The object is to confirm lack of spinal segment movement (fusion), as opposed to increased movement (ROM) for Persona IQ knee patients. Algorithms can be developed to quantify and stratify (5th to 95th percentile) normal/abnormal patient activity and interbody kinematic metrics obtained daily during recovery; sort and filter algorithms can identify “outliers” and alert care teams to individuals needing enhanced, personalized care. Individualized physiotherapy, exercise programs, and therapy guided by objective data can help patients recover better and faster – at home remotely. Machine learning applied to the generated data set can search for potential complications (subsidence, infection, painful gait, DVT, etc). Rich, objective, post-operative data can be combined with rich, interoperative data to inform everything from patient selection and surgical technique to implant design. (Apologies if you have heard this before) Spine surgeons are anxious to have objective data: 87% would use this technology if it was available; only 6% were “somewhat” negative; the best acceptance rates I have seen for a novel device concept. Canary plans to make this technology widely available, either by making a “generic” interbody cage to deliver CHIRP-lc, or by working with existing manufacturers to modify their devices to accept a “smart” cartridge. If any company is willing to go first and invest, let me know - you can get a couple of years’ head start!

77

9 Comments

On October 10th I'm diving deeper into what makes MedTech startup projects unique and difficult to manage with traditional methodology, as well as sharing my tips for avoiding the most common pitfalls in MedTech product development.

30

Another good medtech strategy article. A centralized, searchable resource for global medtech regulations is a game-changer. Here are two key benefits: 1. Easier access to documents streamlines the approval process, potentially accelerating time to market for critical devices. 2. A clearer understanding of global regulations can fuel innovation in underserved markets, improving access to healthcare technologies. #MedTech #Policy #GlobalHealth https://lnkd.in/gJWTMQPb

10

However, if they don’t understand the art of design and where the failures lie in manufacturing a lot of resources will be wasted and failures will inevitably occur. Read more 👉 https://lttr.ai/ATHhh #orthopedicimplants #implants #failedback #AdditiveManufacturing #Medical3Dprinting #3Dprint #AlyssaHuffman

1

Take a listen to our very own Jeremy Langsam on the Funding Medtech Podcast! Jeremy discusses the Portal model, our investment thesis, our growth geographies, and our proprietary A.I. software, Stargaze. Great job, Jeremy - tune in below!

23

2 Comments

⚡️MedTech News Flash⚡️ Medical robotics company Clarapath has partnered with Mayo Clinic to advance pathology laboratories through automation using robotics and artificial intelligence. Traditionally, labs relied on manual processes to handle tissue samples. This dependence was susceptible to labor shortages and quality control issues. Clarapath’s automated system leverages standardized slide outputs and quantitative quality metrics to reduce errors and expedite sample processing. Clarapath’s technology and Mayo Clinic’s clinical expertise are poised to digitalize histology processes worldwide. Automation helps labs efficiently handle caseloads and improve patient care. Dr. Joaquín García from Mayo Clinic, who joined Clarapath’s board, stated: “By working with Clarapath, we are building the foundation for a ‘lab of the future’ that incorporates end-to-end automation, robotics, and AI to the patient tissue lifecycle.” Source: https://lnkd.in/euJ7VTdT Astron Medtech Preteeth AI Aulea Medical Inc. DotSpace #orthopedic #MinimallyInvasiveSurgery #AchillesTendon #AstronMedtech #Dentistry #AIinDentistry #DentalTech #SameDayDentistry #DigitalDentistry #DentalRestoration #DentalCAD #DigitalSmileDesign #Crown #Nightguard #urology #medicaldevice #health #AUA #TURP #Bladder #prostate #urologysurgery #Bladdertumor #Olympus #CriticalCare #PostOperativeCare #IntraAbdominalPressureMonitor #MedicalDevice #DigitalCapsule #ResearchandDevelopment #Manufacturing

1

🚀 New Episode Alert! Ep.80 🎙️ In the latest Medtech Business Academy episode, Mike Sperduti, Scott F. Alexander, and Thomas Hickey explore the evolving relationship between sales and marketing in medtech. They share insights on lead quality, the impact of digital campaigns, and how thought leadership can drive growth. 🔑 Key takeaway: Aligning sales and marketing is essential for pipeline success! Tune in now for actionable strategies to boost your medtech business. 🎧 #Medtech #SalesAndMarketing #ThoughtLeadership #LeadGeneration #Podcast Listen here: https://bit.ly/4dD37a9 Watch here: https://bit.ly/3BkPkaG

7

Another great episode of the #MedtechBusinessAcademy! Watch on YouTube: https://lnkd.in/ez5bGqBX

4

Transparency on cost targets with vendors matters! Samantha Wagner knows first hand how it drives smarter device development and collaboration. Check out the full episode for more tips and tricks to win in medtech. Link in the comments below! #medtech #innovation #supplier #medicaldevice #contractmanufacturing

12

2 Comments

The proxy fight between Masimo and Politan Capital Management continues to heat up ahead of the #digitalhealth pioneer’s July 25 shareholders meeting. Check out the latest developments below. #medtech #meddevice

1

1 Comment

Creating a MedTech ecosystem is something I want to develop over time. It is an extremely difficult task because the amount of moving parts are "infinite" in a sense. Putting that vision into a realistic structure starts somewhere though. The team around me is helping tremendously to make that vision a reality. These people believe in me as much as I believe in them because it is a harmony and we have fun with it. A bunch of my clients are on board into this vision too! First off, they love the results/delivery of any engagement. Why wouldn't they be interested in being part of a world where their brand+mission is being elevated? We elevate one another. Think about Apple and Tim Cook/Steve Jobs. Customer experience is such a valuable asset. Positive or negative feedback helps in ways I never imagined because I give my customers the freedom to say what is on their mind and I do the same in a professional sense - this is exactly how you build and develop a STRONG relationship for the long run. Apple's ecosystem is untouchable for a variety of reasons (many of you know this because you use their products and systems like I do). At the end of the day, if you are obsessed with your customers and their values, a karmic energy comes back to you in a cascade, and it resonates throughout your ecosystem. 🙏 svatantrya #blessed #letsfindout #devanfamlovesanalogies

15

18 Comments

Getting our series started that will be focused on the Contract Manufacturing sector of the medical device industry. Steve Maxson and I will be chatting with individuals that are part of "the engine of medical device". Private equity, owners, engineers, strategics that closely partner with CM's, and we will be discussing the innovations occurring and the careers being built in the contract manufacturing sector. In this session, Steve and I discuss how contract manufacturing and the specialization occuring in it is leading the way in medtech breakthroughs on processes, materials, and technologies. The members of the contract manufacturing players in the medtech space deserve the coverage and highlighting and what they bring to patients. Full session in Comments

106

21 Comments

60% of development costs are spent in the concept phase. If you're not focusing on the riskiest part of your design first, you'll have a ticking time-bomb You have a hole in your boat, what do you do next? You don't worry about the paddles or rudder. You figure out how to plug the hole. If you're not sure how to identify the riskiest part of your design is: 1. Identify the mechanisms driving your core value propositions 2. Isolate the components most directly driving those mechanisms 3. Quantify required performance: are you hitting it with the current design? The design change required might force a modification to the form factor or material, impacting adjacent components, or maybe the entire product. And that larger change to the product changes the orbit of everything else.

16

2 Comments